Literature DB >> 15240734

A3 adenosine receptor signaling contributes to airway inflammation and mucus production in adenosine deaminase-deficient mice.

Hays W J Young1, Jose G Molina, Dawn Dimina, Hongyan Zhong, Marlene Jacobson, Lee-Nien L Chan, Teh-Sheng Chan, James J Lee, Michael R Blackburn.   

Abstract

Adenosine signaling has been implicated in chronic lung diseases such as asthma and chronic obstructive pulmonary disease; however, the specific roles of the various adenosine receptors in processes central to these disorders are not well understood. In this study, we have investigated the role(s) of the A(3) adenosine receptor in adenosine-dependent pulmonary inflammation observed in adenosine deaminase (ADA)-deficient mice. The A(3) receptor (A(3)R) was found to be expressed in eosinophils and mucus-producing cells in the airways of ADA-deficient mice. Treatment of ADA-deficient mice with MRS 1523, a selective A(3)R antagonist, prevented airway eosinophilia and mucus production. Similar findings were seen in the lungs of ADA/A(3) double knockout mice. Although eosinophils were decreased in the airways of ADA-deficient mice following antagonism or removal of the A(3)R, elevations in circulating and lung interstitial eosinophils persisted, suggesting signaling through the A(3)R is needed for the migration of eosinophils into the airways. These findings identify an important role for the A(3)R in regulating lung eosinophilia and mucus production in an environment of elevated adenosine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15240734     DOI: 10.4049/jimmunol.173.2.1380

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

Review 1.  The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

Review 2.  Adenosine receptors and asthma.

Authors:  R A Brown; D Spina; C P Page
Journal:  Br J Pharmacol       Date:  2008-03       Impact factor: 8.739

Review 3.  Adenosine signaling and the regulation of chronic lung disease.

Authors:  Yang Zhou; Daniel J Schneider; Michael R Blackburn
Journal:  Pharmacol Ther       Date:  2009-05-05       Impact factor: 12.310

4.  Enhanced airway inflammation and remodeling in adenosine deaminase-deficient mice lacking the A2B adenosine receptor.

Authors:  Yang Zhou; Amir Mohsenin; Eva Morschl; Hays W J Young; Jose G Molina; Wenbin Ma; Chun-Xiao Sun; Hector Martinez-Valdez; Michael R Blackburn
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

Review 5.  Adenosine receptors and asthma.

Authors:  Constance N Wilson; Ahmed Nadeem; Domenico Spina; Rachel Brown; Clive P Page; S Jamal Mustafa
Journal:  Handb Exp Pharmacol       Date:  2009

6.  Internalization and desensitization of adenosine receptors.

Authors:  Elisabeth C Klaasse; Adriaan P Ijzerman; Willem J de Grip; Margot W Beukers
Journal:  Purinergic Signal       Date:  2007-11-13       Impact factor: 3.765

Review 7.  Mouse models in hematopoietic stem cell gene therapy and genome editing.

Authors:  Stefan Radtke; Olivier Humbert; Hans-Peter Kiem
Journal:  Biochem Pharmacol       Date:  2019-11-06       Impact factor: 5.858

8.  Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice.

Authors:  Almut Grenz; Jessica D Bauerle; Julee H Dalton; Douglas Ridyard; Alexander Badulak; Eunyoung Tak; Eóin N McNamee; Eric Clambey; Radu Moldovan; German Reyes; Jost Klawitter; Kelly Ambler; Kristann Magee; Uwe Christians; Kelley S Brodsky; Katya Ravid; Doo-Sup Choi; Jiaming Wen; Dmitriy Lukashev; Michael R Blackburn; Hartmut Osswald; Imogen R Coe; Bernd Nürnberg; Volker H Haase; Yang Xia; Michail Sitkovsky; Holger K Eltzschig
Journal:  J Clin Invest       Date:  2012-01-24       Impact factor: 14.808

9.  Alterations in adenosine metabolism and signaling in patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.

Authors:  Yang Zhou; Jayasimha N Murthy; Dewan Zeng; Luiz Belardinelli; Michael R Blackburn
Journal:  PLoS One       Date:  2010-02-16       Impact factor: 3.240

10.  Activation of the A(3) adenosine receptor suppresses superoxide production and chemotaxis of mouse bone marrow neutrophils.

Authors:  Dharini van der Hoeven; Tina C Wan; John A Auchampach
Journal:  Mol Pharmacol       Date:  2008-06-26       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.